JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cubeddu, L.
Right arrow Articles by Weiner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cubeddu, L., X.
Right arrow Articles by Weiner, N.
Journal of Pharmacology And Experimental Therapeutics, Vol. 191, Issue 3, 444-457, 1974
Copyright © 1974 by American Society for Pharmacology and Experimental Therapeutics


RELEASE OF NOREPINEPHRINE AND DOPAMINE-beta-HYDROXYLASE BY NERVE STIMULATION. II. EFFECTS OF PAPAVERINE

L. Cubeddu X. 1, E. Barnes 1, and N. Weiner 1

1 Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado

Papaverine, at a concentration which inhibits spleen phosphodiesterase activity (PDE), produces a marked increase in the nerve stimulation-mediated overflow of norepinephrine (NE), 3H-NE, total 3H and dopamine-beta-hydroxylase (DBH) activity from the isolated, perfused cat spleen which had been prelabeled with 3H-NE. Spontaneous outflow of total 3H recovered as 3H-3,4-dihydroxyphenylethyleneglycol is also increased by papaverine. A positive, highly significant correlation between spontaneous release of total 3H and nerve stimulation-mediated release of both total 3H and DBH was observed. The increase in the nerve stimulation-mediated overflow of NE and DBH obtained with 0.1 mM papaverine was several-fold larger than that observed in the presence of the PDE inhibitors, 1-methyl-3-isobutylxanthine (MIX) or 4(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (BMI) (Ro 20-1724). In addition, neither MIX nor BMI enhanced the spontaneous outflow of 3H-deaminated metabolites. Pretreatment with MIX (0.5 mM) or BMI (0.5 mM) did not prevent papaverine effects either on the outflow of 3H-3, 4-dihydroxyphenylethyleneglycol or on the nerve stimulation-mediated outflow of NE and DBH activity. These results indicate that accumulation of 3', 5'-cyclic adenosine monophosphate subsequent to inhibition of PDE activity by papaverine probably accounts for only part of the enhanced release of NE and DBH by nerve stimulation. Since the enhanced spontaneous release of 3H and the enhanced release of neurotransmitter associated with nerve stimulation are highly correlated, the results suggest that a direct effect of papaverine on the synaptic vesicles and its effect on the nerve stimulation-mediated release of NE and DBH could be related.

Submitted on April 15, 1974
Accepted on July 8, 1974







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics.